Association News

BIO 2013 International Convention spotlights BRIC strategies.

Press Release Summary:

Feb 18, 2013 - With one-third of attendees being international, 2013 BIO International Convention will host range of programming focused on opportunities within emerging markets and strategies for growing global biotech industry. Event takes place April 22–25, 2013 in Chicago, IL. In comment, BIO president and CEO Jim Greenwood noted economic priority and resource allocation given biotehnology by many countries and called their participation "vital in presenting a global meeting for the biotech community."

Biotechnology Industry Organization - Washington, DC

Original Press Release

International Program Spotlights the BRICs at the 2013 BIO International Convention

Press release date: Feb 13, 2013

The global event for biotech to take place in Chicago, IL April 22-25, 2013

WASHINGTON--With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities within emerging markets and strategies for growing the global biotech industry. Hosted by the Biotechnology Industry Organization (BIO), the Convention, celebrating its 20th anniversary, will take place April 22-25, 2013 at McCormick Place in Chicago, Ill.

“Biotechnology innovation is an engine of economic growth. Many countries have thus made the development of a biotechnology sector an economic priority and have allocated significant resources into its development”

“Biotechnology innovation is an engine of economic growth. Many countries have thus made the development of a biotechnology sector an economic priority and have allocated significant resources into its development,” said BIO President & CEO Jim Greenwood. “We are pleased to see this reflected in our international audience whose participation is vital in presenting a global meeting for the biotech community.”

The emerging markets are becoming increasingly attractive as governments implement national strategies for biotechnology growth and development. The Spotlights on the BRICs program will be held Monday, April 22nd and will highlight and explore the development strategies of the four BRIC (Brazil, Russia, India and China) nations.

Spotlight on the BRICs: China

Welcome & Opening Presentation, 8:30 – 9:00 a.m.
Key Technical Issues and SFDA Drug Approval Process, 9:00-9:50 a.m.
Recent Developments in China's Biomedicine Industry, 10:00-10:55 a.m.
Building a World-Class Innovative Therapeutic Biologics Industry in China, 11:00-12:00 p.m.
Spotlight on the BRICs: Russia

Welcome & Keynote Presentation, 8:30 – 9:15 a.m.
Pharma 20/20. Russia’s Transformation From Emerging to One of the Fastest Growing Pharmaceutical Markets, 9:15 – 10:30 a.m.
The Role of the Biotech Clusters in the Modernization and Technological Development of the Russian Economy, 10:45 – 12:00 p.m.

Spotlight on the BRICs: Brazil

Investing in Biotechnology in Brazil: Government and Financial Agencies, 1:30 – 2:45 p.m.
Investing in Biotechnology in Brazil: View from the Biopharmaceutical Industry, 3:00 – 4:15 p.m.
Industrial Biotechnology in a New Geography of Innovation: Brazilian Perspectives in Biofuels and Bio-based Chemicals, 4:30 – 5:15 p.m.

Spotlight on the BRICs: India

Opening & Keynote Presentation, 1:45 – 2:30 p.m.
India’s Vision for Biotechnology, 2:45 – 4:00 p.m.
Biotechnology in India’s States, 4:15 – 5:30 p.m.
In addition to the BRIC special program, there are several other sessions within the International Spotlights track. These include:

Global Biotechnology Forum
Tuesday, April 23rd, 8:30 – 10:00 a.m.
Increasing Access to Medicines: Regulatory Approval Systems in Emerging Markets
Tuesday, April 23rd, 10:30 – 11:30 a.m.
How to Adapt: International Consortium Lays Groundwork for Adaptive Licensing
Tuesday, April 23rd, 2:30 – 3:30 p.m.
Health is Wealth: International Cooperation is Advancing Health, Growth and Business Opportunities
Tuesday, April 23rd, 3:45 – 5:00 p.m.
Role Public-Private Partnerships in Addressing Non-Communicable Diseases in Low-and-Middle Income Countries
Wednesday, April 24th, 9:00 – 10:15 a.m.
Global Regulation of Biosimilars: Issues of Importance in Latin America
Wednesday, April 24th, 10:00 – 11:30 a.m.
Biopharma Opportunities in Global Health
Wednesday, April 24th, 10:30 – 11:30 a.m.
Biologics and Regional Trade Agreements
Wednesday, April 24th, 2:30 – 3:30 p.m.

Furthermore, the International Market Briefings Track will give countries and regions around the world the opportunity to present specific initiatives to generate promising new discoveries, create jobs, and spur economic growth and development. Specifically, this track will explore the impact of biotechnology regulation and other government policies on the growth and development of domestic biotechnology sectors. The IMB track will showcase examples from around the world of specific regulatory initiatives that have had, or will have, a real impact on biotechnology investment, approvals, and introduction to the marketplace. These include:

Lithuanian Biotechs – Innovations in Health
Monday, April 22nd, 9:00 – 9:45 a.m.
Advances and Emerging Trends in the Swiss Biotech Market
Monday, April 22nd, 10:00 – 10:45 a.m.
Dutch Biotech Companies: From Start-Up to Exit
Monday, April 22nd, 2:15 – 3:00 p.m.
Turkey: An Investment Opportunity and Hub for Growth in Biotechnology
Monday, April 22nd, 3:15 – 5:00 p.m.
Can Israel Become the Next Biotech Start-Up Nation?
Tuesday, April 23rd, 9:00 – 9:45 a.m.
Government Initiatives in New Drug Development in South Korea
Tuesday, April 23rd, 11:00 – 11:45 a.m.
Market Access in Europe – Pricing in Germany and its Impact on Other Countries
Tuesday, April 23rd, 2:15 – 3:00 p.m.
Regulatory Review and Market Uptake of Biosimilars: The European Experience
Tuesday, April 23rd, 3:15 – 5:00 p.m.
Biotechnology Regulations and Public Policies in Argentina: Impact on Biobusines
Wednesday, April 24th, 9:00 – 9:45 a.m.
Success Stories: How Emerging Belgian Biotechs are Going Public
Wednesday, April 24th, 10:00 – 10:45 a.m.
Innovation & Solutions for Agricultural Biotechnology in Taiwan
Wednesday, April 24th, 11:00 – 11:45 a.m.
Biotechnology Markets Expanding in Mexico
Wednesday, April 24th, 2:15 – 3:00 p.m.
How Brazil is Promoting the Production of Biologicals
Wednesday, April 24th, 3:15 – 4:00 p.m.
ACCINOV: A Unique Regulatory and Technological Environment for Biomanufacturing in France
Wednesday, April 24th, 4:15 – 5:00 p.m.

To learn more about the program and available registration packages for Convention, please visit here.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.

BIO performs many services for members, but none is more visible than the BIO International Convention. The Convention helps BIO fulfill its mission to help grow the global biotech industry. The event supports BIO‘s ongoing programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotech innovation.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO IPCC Conference
March 25-27, 2013
San Diego, CA

BIO International Convention
April 22 – 25, 2013
Chicago, IL

World Congress on Industrial Biotechnology
June 16-19, 2013
Montreal, Canada


Biotechnology Industry Organization
Abigail Hirsch, 202-962-9230
Twitter: @IAmBiotech